OncoVista Innovative Therapies, Inc.
OVIT
$0.0001
-$0.0001-50.00%
OTC PK
| 09/30/2015 | 06/30/2015 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -83.15% | 728.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -70.84% | 298.90% | |||
| Operating Income | 70.84% | -298.90% | |||
| Income Before Tax | 70.25% | -294.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 70.25% | -294.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 70.25% | -294.88% | |||
| EBIT | 70.84% | -298.90% | |||
| EBITDA | 70.85% | -299.01% | |||
| EPS Basic | 71.59% | -295.24% | |||
| Normalized Basic EPS | 71.59% | -293.67% | |||
| EPS Diluted | 71.59% | -295.24% | |||
| Normalized Diluted EPS | 71.59% | -293.67% | |||
| Average Basic Shares Outstanding | 4.73% | 0.00% | |||
| Average Diluted Shares Outstanding | 4.73% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||